Literature DB >> 15529916

A reverse perfusion pattern during Technetium-99m stress myocardial perfusion imaging does not predict flow limiting coronary artery disease.

E J Smith1, A Hussain, M Manoharan, H J Testa, N P Curzen.   

Abstract

BACKGROUND: A reverse redistribution pattern during myocardial perfusion imaging is most widely described using thallium (Tl-201), when stress images exhibit greater perfusion than rest. Technetium (Tc-99 m) radiopharmaceuticals may also yield a reverse perfusion (RP) pattern, but its significance is uncertain. This study tested the hypothesis that RP correlates with the presence and location of flow limiting coronary stenosis(es).
METHOD: We reviewed 842 consecutive Tc-99 m tetrofosmin SPECT stress studies performed at a cardiothoracic centre over a 15 month period. 69 (8.2%) demonstrated RP. Thirty-three patients (age 32-79 mean 56, 17 female) had undergone cardiac catheterisation within 12 months of the scan. Correlation was sought between the presence and location of angiographic stenoses and RP pattern.
RESULTS: 10/33 (30.3%) had significant (>60%) coronary stenosis(es); 5 single-vessel, 2 two-vessel and 3 three-vessel disease (3VD). Stenosis location correlated poorly with the RP territory (LAD/Anterior 5/17, RCA/Inferior 1/10, Cx/lateral 0/4 (p = 0.57)). Of the 6 patients with a lesion in the RP territory, 3 had 3VD; 2 of these had a simultaneous reversible defect. All 5 patients with previous myocardial infarction had a simultaneous fixed defect. However only 3/12 with co-existent reversible defects had significant disease.
CONCLUSION: The reverse perfusion pattern is a poor predictor of flow limiting coronary disease, and does not correlate with stenosis location in those with significant lesions. Such patients should not undergo invasive investigation purely on the basis of this result.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15529916     DOI: 10.1023/b:caim.0000041951.48335.1a

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  24 in total

1.  Duodenogastric reflux on (99m)Tc-tetrofosmin myocardial SPECT mimics left ventricle inferior wall reverse redistribution and falsely decreases ejection fraction: a case report.

Authors:  P Donovan; V Kieffer; W J Shih
Journal:  J Nucl Med Technol       Date:  2001-12

2.  Significant enterogastric reflux secondary to Billroth II gastrectomy leads to reverse redistribution of the inferior wall of the left ventricle on dipyridamole Tc-99m tetrofosmin myocardial spect.

Authors:  W J Shih; P Donovan; V Kiefer
Journal:  Clin Nucl Med       Date:  2001-06       Impact factor: 7.794

3.  Stress thallium-201 transaxial emission computed tomography: quantitative versus qualitative analysis for evaluation of coronary artery disease.

Authors:  N Tamaki; Y Yonekura; T Mukai; S Kodama; K Kadota; H Kambara; C Kawai; K Torizuka
Journal:  J Am Coll Cardiol       Date:  1984-12       Impact factor: 24.094

4.  Reverse redistribution phenomenon in thallium-201 stress tests: angiographic correlation and clinical significance.

Authors:  E B Silberstein; D F DeVries
Journal:  J Nucl Med       Date:  1985-07       Impact factor: 10.057

5.  Reverse redistribution: worsening of thallium-201 myocardial images from exercise to redistribution.

Authors:  H S Hecht; J M Hopkins; J G Rose; D E Blumfield; M Wong
Journal:  Radiology       Date:  1981-07       Impact factor: 11.105

6.  Improved diagnostic performance of exercise thallium-201 single photon emission computed tomography over planar imaging in the diagnosis of coronary artery disease: a receiver operating characteristic analysis.

Authors:  D J Fintel; J M Links; J A Brinker; T L Frank; M Parker; L C Becker
Journal:  J Am Coll Cardiol       Date:  1989-03-01       Impact factor: 24.094

7.  Reverse redistribution of 99m Tc-sestamibi after direct percutaneous transluminal coronary angioplasty in acute myocardial infarction: relationship with wall motion and functional response to dobutamine stimulation.

Authors:  S Fujiwara; Y Takeishi; O Hirono; A Fukui; M Okuyama; S Yamaguchi; M Ito; K Kaneko; T Shishido; T Miyamoto; K Yuki; T Miyashita; K Takahashi; O Minamihaba; H Tomoike; S Yamauchi; K Fatema
Journal:  Nucl Med Commun       Date:  2001-11       Impact factor: 1.690

8.  High prevalence of (99m)tc-tetrofosmin reverse perfusion pattern in patients with myocardial infarction and angiographically smooth coronary arteries.

Authors:  Gabriele Fragasso; Sergio L Chierchia; Flaviano Dosio; Enrico Rossetti; Luigi Gianolli; Maria Picchio; Alberto Margonato; Ferruccio Fazio
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

9.  Reverse redistribution of thallium-201 detected by SPECT imaging after dipyridamole in angina pectoris.

Authors:  J J Popma; T C Smitherman; B S Walker; T R Simon; G J Dehmer
Journal:  Am J Cardiol       Date:  1990-05-15       Impact factor: 2.778

10.  Clinical significance of reverse redistribution on thallium-201 single-photon emission computed tomography in patients with acute myocardial infarction.

Authors:  H Yamagishi; H Itagane; K Akioka; T Ohmura; H Iida; A Tahara; I Toda; M Teragaki; K Takeuchi; T Takeda
Journal:  Jpn Circ J       Date:  1992-11
View more
  3 in total

1.  Non-invasive diagnosis of in stent stenosis by stress 99m technetium tetrofosmin myocardial perfusion imaging.

Authors:  Abdou Elhendy; Arend F L Schinkel; Ron T van Domberg; Jeroen J Bax; Roelf Valkema; Don Poldermans
Journal:  Int J Cardiovasc Imaging       Date:  2006-04-21       Impact factor: 2.357

2.  Reverse redistribution pattern in rest Tl-201 and stress Tc-99m SPECT in patients undergoing coronary interventions.

Authors:  Naoya Matsumoto; Shunichi Yoda; Ken Nagao; Atsushi Hirayama
Journal:  BMJ Case Rep       Date:  2014-04-17

3.  Impaired myocardial SPECT imaging secondary to silicon- and saline-containing breast implants.

Authors:  Curtiss T Stinis; Paul E Lizotte; Mohammad-Reza Movahed
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-15       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.